Anaptysbio (ANAB) Free Cash Flow (2016 - 2026)
Anaptysbio posted quarterly Free Cash Flow of -$25.9 million for Q1 2026, down 141.6% year-on-year from $62.3 million in Q1 2025, and down 126.47% on a QoQ basis from $98.0 million in Q4 2025.
Anaptysbio (ANAB) has 11 years of Free Cash Flow data on file, last reported at -$25.9 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 141.6% year-over-year to -$25.9 million; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (up 104.04% YoY), and the FY2025 full-year result was $19.6 million, up 114.45% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$25.9 million, down from $98.0 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $98.0 million in Q4 2025 and bottomed at -$66.9 million in Q4 2024.
- The 5-year median for Free Cash Flow is -$24.7 million (2023), against an average of -$19.8 million.
- The widest annual swing landed in 2022, when Free Cash Flow plunged 377.97%; it then soared 246.4% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$10.8 million in 2022, then tumbled by 222.61% to -$34.9 million in 2023, then plunged by 91.92% to -$66.9 million in 2024, then jumped by 246.4% to $98.0 million in 2025, then plunged by 126.47% to -$25.9 million in 2026.
- The last three Free Cash Flow figures came in at -$25.9 million (Q1 2026), $98.0 million (Q4 2025), and -$27.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - | -25.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.94 Mn |
| Mar 31, 2026 | -25.94 Mn |
| Dec 31, 2025 | 98.00 Mn |
| Dec 31, 2025 | 98.00 Mn |
| Sep 30, 2025 | -27.37 Mn |
| Sep 30, 2025 | -27.37 Mn |
| Jun 30, 2025 | -40.28 Mn |
| Jun 30, 2025 | -40.28 Mn |
| Mar 31, 2025 | -10.74 Mn |
| Mar 31, 2025 | -10.74 Mn |
| Dec 31, 2024 | -66.94 Mn |
| Dec 31, 2024 | -66.94 Mn |
| Sep 30, 2024 | -10.13 Mn |
| Sep 30, 2024 | -10.13 Mn |
| Jun 30, 2024 | -21.36 Mn |
| Jun 30, 2024 | -21.36 Mn |
| Mar 31, 2024 | -37.28 Mn |
| Mar 31, 2024 | -37.28 Mn |
| Dec 31, 2023 | -34.88 Mn |
| Dec 31, 2023 | -34.88 Mn |
| Sep 30, 2023 | -36.70 Mn |
| Sep 30, 2023 | -36.70 Mn |
| Jun 30, 2023 | -25.29 Mn |
| Jun 30, 2023 | -25.29 Mn |
| Mar 31, 2023 | -24.74 Mn |
| Mar 31, 2023 | -24.74 Mn |
| Dec 31, 2022 | -10.81 Mn |
| Dec 31, 2022 | -10.81 Mn |
| Sep 30, 2022 | -17.64 Mn |
| Sep 30, 2022 | -17.64 Mn |
| Jun 30, 2022 | -24.26 Mn |
| Jun 30, 2022 | -24.26 Mn |
| Mar 31, 2022 | -21.03 Mn |
| Mar 31, 2022 | -21.03 Mn |
| Dec 31, 2021 | -25.32 Mn |
| Dec 31, 2021 | -25.32 Mn |
| Sep 30, 2021 | -5.84 Mn |
| Sep 30, 2021 | -5.84 Mn |
| Jun 30, 2021 | 8.73 Mn |
| Jun 30, 2021 | 8.73 Mn |
| Mar 31, 2021 | -23.52 Mn |
| Mar 31, 2021 | -23.52 Mn |
| Dec 31, 2020 | 37.17 Mn |
| Dec 31, 2020 | 37.17 Mn |
| Sep 30, 2020 | -17.01 Mn |
| Sep 30, 2020 | -17.01 Mn |
| Jun 30, 2020 | -19.69 Mn |
| Jun 30, 2020 | -19.69 Mn |
| Mar 31, 2020 | -15.20 Mn |
| Mar 31, 2020 | -15.20 Mn |
| Dec 31, 2019 | -16.53 Mn |
| Dec 31, 2019 | -16.53 Mn |
| Sep 30, 2019 | -22.16 Mn |
| Sep 30, 2019 | -22.16 Mn |
| Jun 30, 2019 | -15.30 Mn |
| Jun 30, 2019 | -15.30 Mn |
| Mar 31, 2019 | -16.33 Mn |
| Mar 31, 2019 | -16.33 Mn |
| Dec 31, 2018 | -11.59 Mn |
| Dec 31, 2018 | -11.59 Mn |
| Sep 30, 2018 | -15.52 Mn |
| Sep 30, 2018 | -15.52 Mn |
| Jun 30, 2018 | -9.07 Mn |
| Jun 30, 2018 | -9.07 Mn |
| Mar 31, 2018 | -12.49 Mn |
| Mar 31, 2018 | -12.49 Mn |
| Dec 31, 2017 | -4.99 Mn |
| Dec 31, 2017 | -4.99 Mn |
| Sep 30, 2017 | -3.75 Mn |
| Sep 30, 2017 | -3.75 Mn |
| Jun 30, 2017 | -2.71 Mn |
| Jun 30, 2017 | -2.71 Mn |
| Mar 31, 2017 | -8.18 Mn |
| Mar 31, 2017 | -8.18 Mn |
| Dec 31, 2016 | -5.63 Mn |
| Dec 31, 2016 | -5.63 Mn |
| Sep 30, 2016 | -3.12 Mn |
| Sep 30, 2016 | -3.12 Mn |
| Jun 30, 2016 | 1.68 Mn |
| Jun 30, 2016 | 1.68 Mn |
| Mar 31, 2016 | -2.06 Mn |
| Mar 31, 2016 | -2.06 Mn |